Efficacy News and Research

RSS
ADVENTRX updates ANX-514 candidate for FDA approval

ADVENTRX updates ANX-514 candidate for FDA approval

Study: BPS is safe and effective for patients undergoing therapeutic endoscopy

Study: BPS is safe and effective for patients undergoing therapeutic endoscopy

Endosense announces completion of enrollment in EFFICAS I clinical study

Endosense announces completion of enrollment in EFFICAS I clinical study

The Lancet publishes Baxter's PREFLUCEL phase III trial results against seasonal influenza

The Lancet publishes Baxter's PREFLUCEL phase III trial results against seasonal influenza

Efficacy of zinc in common cold - Review of clinical trials

Efficacy of zinc in common cold - Review of clinical trials

Study shows lower success rate of FDA drug approval from 2003 to 2010

Study shows lower success rate of FDA drug approval from 2003 to 2010

Screening breast MRIs can detect invasive cancers in women with history of chest irradiation

Screening breast MRIs can detect invasive cancers in women with history of chest irradiation

U-Systems completes pivotal study for automated breast ultrasound cancer screening

U-Systems completes pivotal study for automated breast ultrasound cancer screening

Chimerix announces completion of $45 million Series F financing

Chimerix announces completion of $45 million Series F financing

BioTime to merge Glycosan with OrthoCyte

BioTime to merge Glycosan with OrthoCyte

Neoprobe achieves accrual goal in Lymphoseek Phase 3 study in breast cancer/melanoma

Neoprobe achieves accrual goal in Lymphoseek Phase 3 study in breast cancer/melanoma

PROLOR reports positive DSMB review of long-acting human growth hormone clinical trial

PROLOR reports positive DSMB review of long-acting human growth hormone clinical trial

Tarsa completes oral calcitonin Phase III trial for treatment of postmenopausal osteoporosis

Tarsa completes oral calcitonin Phase III trial for treatment of postmenopausal osteoporosis

OXiGENE, NCI/CTEP and GOG collaborate on ZYBRESTAT Phase 2 study in relapsed ovarian cancer

OXiGENE, NCI/CTEP and GOG collaborate on ZYBRESTAT Phase 2 study in relapsed ovarian cancer

Numira acquires Ricerca' Efficacy Pharmacology operating unit

Numira acquires Ricerca' Efficacy Pharmacology operating unit

Oestrogen reduces risk of breast cancer: Study

Oestrogen reduces risk of breast cancer: Study

BioCentury features ImmunGene's interferon payload technology and cancer antibodies

BioCentury features ImmunGene's interferon payload technology and cancer antibodies

Last patient in EU Diamyd Phase III clinical study completes 15-month visit for type 1 diabetes

Last patient in EU Diamyd Phase III clinical study completes 15-month visit for type 1 diabetes

The Lancet publishes CHAMPION trial results against heart failure

The Lancet publishes CHAMPION trial results against heart failure

JTH publishes positive TB-402 Phase II trial results for VTE treatment after orthopaedic surgery

JTH publishes positive TB-402 Phase II trial results for VTE treatment after orthopaedic surgery

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.